
The Cooper Companies Experiences Revision in Stock Evaluation Amid Market Dynamics
2025-12-01 16:02:53The Cooper Companies, Inc. has recently revised its evaluation amid market fluctuations, with its stock priced at $77.93. Over the past year, it has seen significant volatility, with a high of $106.63 and a low of $61.77. The company's performance contrasts with the S&P 500, showing mixed returns.
Read MoreIs The Cooper Cos., Inc. overvalued or undervalued?
2025-11-11 11:12:37As of 7 November 2025, the valuation grade for The Cooper Cos., Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value but still suggesting overvaluation. The company is considered overvalued based on its P/E ratio of 36, which is significantly higher than peers such as Hologic, Inc. with a P/E of 21.83 and Align Technology, Inc. at 20.46. Additionally, the EV to EBITDA ratio stands at 15.35, which is also elevated compared to the industry average. The Cooper Cos., Inc. shows a PEG ratio of 1.69, further highlighting its expensive valuation relative to growth expectations. The return comparison reveals that the stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -23.07% compared to the S&P 500's 14.40%. This trend reinforces the notion that the stock is overvalued in the current market context....
Read More
The Cooper Companies Experiences Revision in Its Stock Evaluation Amid Market Challenges
2025-11-10 15:32:19The Cooper Companies, Inc. has recently adjusted its valuation, with a current P/E ratio of 36 and a price-to-book value of 1.78. The company has faced performance challenges, showing a year-to-date return of -23.75% and a decline of 32.16% over the past year, compared to the S&P 500.
Read MoreIs The Cooper Cos., Inc. overvalued or undervalued?
2025-11-10 11:13:51As of 7 November 2025, the valuation grade for The Cooper Cos., Inc. has moved from very expensive to expensive, indicating a shift in perception but still suggesting a high valuation. The company appears overvalued based on its current metrics, with a P/E ratio of 36, a Price to Book Value of 1.78, and an EV to EBITDA of 15.35. In comparison, peers such as Hologic, Inc. and Align Technology, Inc. have lower P/E ratios of 21.83 and 20.46, respectively, which further supports the notion that The Cooper Cos., Inc. is priced at a premium relative to its industry. Additionally, the company has underperformed significantly against the S&P 500, with a year-to-date return of -23.75% compared to the index's 14.40%. This stark contrast in performance reinforces the view that The Cooper Cos., Inc. is overvalued in the current market environment....
Read MoreIs The Cooper Cos., Inc. overvalued or undervalued?
2025-11-09 11:07:24As of 7 November 2025, the valuation grade for The Cooper Cos., Inc. has moved from very expensive to expensive. The company appears to be overvalued based on its current financial metrics. The P/E ratio stands at 36, significantly higher than peers like Hologic, Inc. with a P/E of 21.83 and Align Technology, Inc. at 20.46. Additionally, the EV to EBITDA ratio of 15.35 is also elevated compared to Hologic's 14.71, indicating a premium valuation relative to its industry counterparts. Despite a recent positive return of 0.27% over the past week compared to the S&P 500's decline of 1.63%, the longer-term performance shows a concerning trend, with a year-to-date return of -23.75% versus the S&P 500's gain of 14.40%. This suggests that while there may be short-term fluctuations, the overall valuation remains high relative to the company's performance and its peers....
Read More
The Cooper Companies Experiences Valuation Adjustment Amidst Market Challenges and Performance Disparities
2025-10-27 15:39:26The Cooper Companies, Inc. has recently adjusted its valuation, with its stock price at $73.51, down from $74.52. Over the past year, it has seen a significant decline of 31.49%. Key financial metrics include a P/E ratio of 36 and a ROCE of 7.04%, indicating elevated valuations compared to peers.
Read MoreIs The Cooper Cos., Inc. overvalued or undervalued?
2025-10-21 11:58:32As of 17 October 2025, the valuation grade for The Cooper Cos., Inc. has moved from fair to very expensive, indicating a significant shift in its valuation outlook. The company is currently considered overvalued, with a P/E ratio of 36, which is notably higher than its peer Hologic, Inc. at 21.83 and Align Technology, Inc. at 20.46. Additionally, the EV to EBITDA ratio stands at 15.35, again exceeding the industry benchmarks, which suggests that the company's valuation metrics are not aligned with its earnings potential. In comparison to its peers, The Cooper Cos., Inc. has a PEG ratio of 1.69, which is higher than Hologic's 2.60, indicating that it is priced at a premium relative to its growth expectations. The company's recent stock performance has been disappointing, with a year-to-date return of -21.71%, significantly underperforming the S&P 500's positive return of 13.30% during the same period. This ...
Read More
The Cooper Companies Experiences Revision in Its Stock Evaluation Amid Market Challenges
2025-10-20 15:50:16The Cooper Companies, Inc. has recently adjusted its valuation, showing a higher P/E ratio compared to peers like Hologic and Baxter. With a ROCE of 7.04% and ROE of 5.00%, the company has faced significant challenges, including a year-to-date return of -21.71% and a five-year decline of 79.65%.
Read MoreIs The Cooper Cos., Inc. overvalued or undervalued?
2025-10-19 11:54:17As of 17 October 2025, The Cooper Cos., Inc. has moved from a fair to a very expensive valuation grade. The company is considered overvalued based on its current metrics, with a P/E ratio of 36, a Price to Book Value of 1.78, and an EV to EBITDA of 15.35. In comparison, peers such as Hologic, Inc. have a more favorable P/E of 21.83, while Align Technology, Inc. shows a significantly lower EV to EBITDA of 11.41, indicating that The Cooper Cos. is priced at a premium relative to its industry counterparts. The stock has underperformed against the S&P 500, with a year-to-date return of -21.71% compared to the index's 13.30%. This trend continues over longer periods, with a 5-year return of -79.65% versus the S&P 500's 91.29%, reinforcing the notion that the stock may not justify its current valuation....
Read More





